<!DOCTYPE html><html lang="en-us" >

<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.2.0 for Hugo" />
  

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Qi Zhao" />

  
  
  
    
  
  <meta name="description" content="Immune-checkpoint inhibitor (ICI) therapy, including antibodies targeting programmed cell death protein 1(PD-1), programmed death-ligand 1 (PD-L1), or cytotoxic T-lymphocyte–associated protein 4 (CTLA4), has demonstrated impressive clinical efficacy in controlling advanced cancers. Recent studies have identified several positive predictive markers for ICI, including high levels of microsatellite instability (MSI-high), PD-L1 overexpression, and elevated tumor mutation burden (TMB).1 The genes that encode DNA polymerase epsilon (POLE) and delta 1 (POLD1) are essential for proofreading and fidelity in DNA replication.2 Their germline or somatic mutations can lead to DNA-repair deficiencies and carcinogenesis via a DNA hypermutated molecular phenotype.3,4 An association between POLE or POLD1 mutations and clinical benefit to ICI has been observed in several case reports.5,6 However, to our knowledge, a comprehensive analysis of POLE or POLD1 mutation frequency and their predictive value for ICI treatment outcome has not yet been reported. In this study, we conducted a combined analysis using a large data set and found that POLE/POLD1 mutations are promising potential predictive biomarkers for positive ICI outcomes." />

  
  <link rel="alternate" hreflang="en-us" href="https://likelet.github.io/publication/journal-article-evaluation/" />

  







  




  
  
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  

  
  
  
  
    
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.9.0/css/academicons.min.css" integrity="sha512-W4yqoT1+8NLkinBLBZko+dFB2ZbHsYLDdr50VElllRcNt2Q4/GSs6u71UHKxB7S6JEMCp5Ve4xjh3eGQl/HRvg==" crossorigin="anonymous">
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.14.0/css/all.min.css" integrity="sha256-FMvZuGapsJLjouA6k7Eo2lusoAX9i0ShlWFG6qt7SLc=" crossorigin="anonymous">

    
    

    
    
    
      
    
    

    
    
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.css" integrity="sha512-1xoFisiGdy9nvho8EgXuXvnpR5GAMSjFwp40gSRE3NwdUdIMIKuPa7bqoUhLD0O/5tPNhteAsE5XyyMi5reQVA==" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      
        
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
    
      
      
      <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato:400,700%7CMerriweather%7CRoboto+Mono&display=swap">
      
    
  

  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.84f6d3f2750c6dae1259b2f1b92da214.css" />

  



  

  

  




  
  
  

  

  
    <link rel="manifest" href="/index.webmanifest" />
  

  <link rel="icon" type="image/png" href="/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://likelet.github.io/publication/journal-article-evaluation/" />

  
  
  
  
  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary" />
  
  <meta property="og:site_name" content="Qizhao Research Group" />
  <meta property="og:url" content="https://likelet.github.io/publication/journal-article-evaluation/" />
  <meta property="og:title" content="Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types | Qizhao Research Group" />
  <meta property="og:description" content="Immune-checkpoint inhibitor (ICI) therapy, including antibodies targeting programmed cell death protein 1(PD-1), programmed death-ligand 1 (PD-L1), or cytotoxic T-lymphocyte–associated protein 4 (CTLA4), has demonstrated impressive clinical efficacy in controlling advanced cancers. Recent studies have identified several positive predictive markers for ICI, including high levels of microsatellite instability (MSI-high), PD-L1 overexpression, and elevated tumor mutation burden (TMB).1 The genes that encode DNA polymerase epsilon (POLE) and delta 1 (POLD1) are essential for proofreading and fidelity in DNA replication.2 Their germline or somatic mutations can lead to DNA-repair deficiencies and carcinogenesis via a DNA hypermutated molecular phenotype.3,4 An association between POLE or POLD1 mutations and clinical benefit to ICI has been observed in several case reports.5,6 However, to our knowledge, a comprehensive analysis of POLE or POLD1 mutation frequency and their predictive value for ICI treatment outcome has not yet been reported. In this study, we conducted a combined analysis using a large data set and found that POLE/POLD1 mutations are promising potential predictive biomarkers for positive ICI outcomes." /><meta property="og:image" content="https://likelet.github.io/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://likelet.github.io/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta
        property="article:published_time"
        content="2019-08-01T00:00:00&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2019-08-01T00:00:00&#43;00:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://likelet.github.io/publication/journal-article-evaluation/"
  },
  "headline": "Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types",
  
  "datePublished": "2019-08-01T00:00:00Z",
  "dateModified": "2019-08-01T00:00:00Z",
  
  "author": {
    "@type": "Person",
    "name": "Feng Wang"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Qizhao Research Group",
    "logo": {
      "@type": "ImageObject",
      "url": "https://likelet.github.io/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_192x192_fill_lanczos_center_3.png"
    }
  },
  "description": "Immune-checkpoint inhibitor (ICI) therapy, including antibodies targeting programmed cell death protein 1(PD-1), programmed death-ligand 1 (PD-L1), or cytotoxic T-lymphocyte–associated protein 4 (CTLA4), has demonstrated impressive clinical efficacy in controlling advanced cancers. Recent studies have identified several positive predictive markers for ICI, including high levels of microsatellite instability (MSI-high), PD-L1 overexpression, and elevated tumor mutation burden (TMB).1 The genes that encode DNA polymerase epsilon (POLE) and delta 1 (POLD1) are essential for proofreading and fidelity in DNA replication.2 Their germline or somatic mutations can lead to DNA-repair deficiencies and carcinogenesis via a DNA hypermutated molecular phenotype.3,4 An association between POLE or POLD1 mutations and clinical benefit to ICI has been observed in several case reports.5,6 However, to our knowledge, a comprehensive analysis of POLE or POLD1 mutation frequency and their predictive value for ICI treatment outcome has not yet been reported. In this study, we conducted a combined analysis using a large data set and found that POLE/POLD1 mutations are promising potential predictive biomarkers for positive ICI outcomes."
}
</script>

  

  

  

  





  <title>Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types | Qizhao Research Group</title>
</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="82e10e9fc6d3ad8f6d053a15ed7c76fc" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.c2ae95842e5b33a787c7b8c567e989a4.js"></script>

  


<aside class="search-modal" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#" aria-label="Close"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control"
        aria-label="Search...">
        
      </div>

      
      

      

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>



  <div class="page-header">
    












<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
  <div class="container-xl">

    
    <div class="d-none d-lg-inline-flex">
      <a class="navbar-brand" href="/">Qizhao Research Group</a>
    </div>
    

    
    <button type="button" class="navbar-toggler" data-toggle="collapse"
            data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
    <span><i class="fas fa-bars"></i></span>
    </button>
    

    
    <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
      <a class="navbar-brand" href="/">Qizhao Research Group</a>
    </div>
    

    
    
    <div class="navbar-collapse main-menu-item collapse justify-content-end" id="navbar-content">

      
      <ul class="navbar-nav d-md-inline-flex">
        

        

        
        
        

        

        
        
        
        

        
          
            
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/post"><span>News</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/people"><span>People</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/publication"><span>Publications</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/contact"><span>Contact</span></a>
        </li>

        
        

      

        
      </ul>
    </div>

    <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

      
      
        
      

      
      
      <li class="nav-item">
        <a class="nav-link js-search" href="#" aria-label="Search"><i class="fas fa-search" aria-hidden="true"></i></a>
      </li>
      

      
      

      
      

    </ul>

  </div>
</nav>


  </div>

  <div class="page-body">
    








<div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      <a href="/author/feng-wang/">Feng Wang</a></span><i class="author-notes fas fa-info-circle" data-toggle="tooltip" title="contributed equally"></i>, <span >
      <a href="/author/qi-zhao/">Qi Zhao</a></span><i class="author-notes fas fa-info-circle" data-toggle="tooltip" title="contributed equally"></i>, <span >
      <a href="/author/ying-nan-wang/">Ying-nan Wang</a></span>, <span >
      <a href="/author/ying-jin/">Ying Jin</a></span>, <span >
      <a href="/author/ming-ming-he/">Ming-Ming He</a></span>, <span >
      <a href="/author/ze-xian-liu/">Ze-xian Liu</a></span>, <span >
      <a href="/author/rui-hua-xu/">Rui-hua Xu</a></span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    August 2019
  </span>
  

  

  

  
  
  
  
  
  

  
  

</div>

    




<div class="btn-links mb-3">
  
  








  





<a href="#" class="btn btn-outline-primary btn-page-header js-cite-modal"
        data-filename="/publication/journal-article-evaluation/cite.bib">
  Cite
</a>





  
    
  









<a class="btn btn-outline-primary btn-page-header" href="https://doi.org/10.1001/jamaoncol.2019.2963" target="_blank" rel="noopener">
  DOI
</a>



</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Immune-checkpoint inhibitor (ICI) therapy, including antibodies targeting programmed cell death protein 1(PD-1), programmed death-ligand 1 (PD-L1), or cytotoxic T-lymphocyte–associated protein 4 (CTLA4), has demonstrated impressive clinical efficacy in controlling advanced cancers. Recent studies have identified several positive predictive markers for ICI, including high levels of microsatellite instability (MSI-high), PD-L1 overexpression, and elevated tumor mutation burden (TMB).1 The genes that encode DNA polymerase epsilon (POLE) and delta 1 (POLD1) are essential for proofreading and fidelity in DNA replication.2 Their germline or somatic mutations can lead to DNA-repair deficiencies and carcinogenesis via a DNA hypermutated molecular phenotype.3,4 An association between POLE or POLD1 mutations and clinical benefit to ICI has been observed in several case reports.5,6 However, to our knowledge, a comprehensive analysis of POLE or POLD1 mutation frequency and their predictive value for ICI treatment outcome has not yet been reported. In this study, we conducted a combined analysis using a large data set and found that POLE/POLD1 mutations are promising potential predictive biomarkers for positive ICI outcomes.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#2">
              Journal article
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9">JAMA Oncology</div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    




<div class="article-tags">
  
  <a class="badge badge-light" href="/tag/source-themes/">Source Themes</a>
  
</div>



<div class="share-box" aria-hidden="true">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=https://likelet.github.io/publication/journal-article-evaluation/&amp;text=Evaluation%20of%20POLE%20and%20POLD1%20Mutations%20as%20Biomarkers%20for%20Immunotherapy%20Outcomes%20Across%20Multiple%20Cancer%20Types" target="_blank" rel="noopener" class="share-btn-twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=https://likelet.github.io/publication/journal-article-evaluation/&amp;t=Evaluation%20of%20POLE%20and%20POLD1%20Mutations%20as%20Biomarkers%20for%20Immunotherapy%20Outcomes%20Across%20Multiple%20Cancer%20Types" target="_blank" rel="noopener" class="share-btn-facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Evaluation%20of%20POLE%20and%20POLD1%20Mutations%20as%20Biomarkers%20for%20Immunotherapy%20Outcomes%20Across%20Multiple%20Cancer%20Types&amp;body=https://likelet.github.io/publication/journal-article-evaluation/" target="_blank" rel="noopener" class="share-btn-email">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://likelet.github.io/publication/journal-article-evaluation/&amp;title=Evaluation%20of%20POLE%20and%20POLD1%20Mutations%20as%20Biomarkers%20for%20Immunotherapy%20Outcomes%20Across%20Multiple%20Cancer%20Types" target="_blank" rel="noopener" class="share-btn-linkedin">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="whatsapp://send?text=Evaluation%20of%20POLE%20and%20POLD1%20Mutations%20as%20Biomarkers%20for%20Immunotherapy%20Outcomes%20Across%20Multiple%20Cancer%20Types%20https://likelet.github.io/publication/journal-article-evaluation/" target="_blank" rel="noopener" class="share-btn-whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=https://likelet.github.io/publication/journal-article-evaluation/&amp;title=Evaluation%20of%20POLE%20and%20POLD1%20Mutations%20as%20Biomarkers%20for%20Immunotherapy%20Outcomes%20Across%20Multiple%20Cancer%20Types" target="_blank" rel="noopener" class="share-btn-weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>











  
  
    




  
    



  
  
  
  
  
  <div class="media author-card content-widget-hr">
    
      
      <a href="/author/qi-zhao/"><img class="avatar mr-3 avatar-circle" src="/author/qi-zhao/avatar_hubfa6ca2e6c68587649f1935fb1a2bafd_156692_270x270_fill_lanczos_center_3.png" alt="Qi Zhao"></a>
    

    <div class="media-body">
      <h5 class="card-title"><a href="/author/qi-zhao/">Qi Zhao</a></h5>
      <h6 class="card-subtitle">Associate Professor of Cancer Bioinformatics</h6>
      <p class="card-text">Qi Zhao is an assistant professor of cancer bioinfomatics at the Sun Yat-sen university cancer center. His research interests include cancer genomics, biosoftware development and high performance computing.</p>
      <ul class="network-icon" aria-hidden="true">
  
    
    
    
      
    
    
    
    
    
    <li>
      <a href="mailto:zhaoqi@sysucc.org.cn" >
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://twitter.com/qi_likelet" target="_blank" rel="noopener">
        <i class="fab fa-twitter"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="https://scholar.google.co.uk/citations?user=j7LCthMAAAAJ" target="_blank" rel="noopener">
        <i class="ai ai-google-scholar"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://github.com/gcushen" target="_blank" rel="noopener">
        <i class="fab fa-github"></i>
      </a>
    </li>
  
</ul>

    </div>
  </div>


  
    




  
    




  
    




  
    




  
    




  














  
  
  <div class="article-widget content-widget-hr">
    <h3>Related</h3>
    <ul>
      
      <li><a href="/publication/journal-article-novel/">Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer</a></li>
      
      <li><a href="/publication/journal-article-rmvar/">RMVar: an updated database of functional variants involved in RNA modifications</a></li>
      
      <li><a href="/publication/journal-article-systematic-analysis/">Systematic analysis of the transcriptome in small‐cell carcinoma of the oesophagus reveals its immune microenvironment</a></li>
      
      <li><a href="/publication/journal-article-targeting/">Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells</a></li>
      
      <li><a href="/publication/journal-article-crossicc/">CrossICC: iterative consensus clustering of cross-platform gene expression data without adjusting batch effect</a></li>
      
    </ul>
  </div>
  





  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  

  

  

  
  






  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-modules" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/instant.page/5.1.0/instantpage.min.js" integrity="sha512-1+qUtKoh9XZW7j+6LhRMAyOrgSQKenQ4mluTR+cvxXjP1Z54RxZuzstR/H9kgPXQsVB8IW7DMDFUJpzLjvhGSQ==" crossorigin="anonymous"></script>

      
      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
        <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      

      
      

      

      

    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.js" integrity="sha512-SeiQaaDh73yrb56sTW/RgVdi/mMqNeM2oBwubFHagc5BkixSpP1fvqF47mKzPGWYSSy4RwbBunrJBQ4Co8fRWA==" crossorigin="anonymous"></script>
    

    
    

    
    
    
      
      <script id="search-hit-fuse-template" type="text/x-template">
        <div class="search-hit" id="summary-{{key}}">
          <div class="search-hit-content">
            <div class="search-hit-name">
              <a href="{{relpermalink}}">{{title}}</a>
              <div class="article-metadata search-hit-type">{{type}}</div>
              <p class="search-hit-description">{{snippet}}</p>
            </div>
          </div>
        </div>
      </script>
      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
        <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
      
    

    
    

    
    
    
    

    
    <script src="/js/bootstrap.bundle.min.6aed84840afc03ab4d5750157f69c120.js"></script>

    
    
      
      
      
      
      
      
      
    

    
    
    
    
    
    
    
    
      
      
    
    
    <script src="/en/js/wowchemy.min.fb8eb32a4d207f5f18023712a904b210.js"></script>

    






</body>
</html>
